NCT06692452 2026-01-07Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Suspended24 enrolled
NCT03113500 2025-11-14Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell LymphomaCity of Hope Medical CenterPhase 2 Active not recruiting48 enrolled 8 charts
NCT01746992 2017-11-14CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell LymphomaRuijin HospitalPhase 4 Unknown200 enrolled